Abstract
Guanylate kinase is a critical enzyme in the biosynthesis of guanosine 5 ′-triphosphate (GTP) and dGTP and is responsible for the phosphorylation of guanosine 5 ′-monophosphate (GMP) and dGMP to guanosine 5 ′-diphosphate (GDP) and dGDP, respectively. As with many nucleotide-metabolizing enzymes, guanylate kinase is involved in antimicrobial and antineoplastic drug activation. This is due to the structural similarities of such agents with nucleobases or nucleosides that are acted upon by endogenous enzymes. Despite the involvement of guanylate kinase in 6-thioguanine, mercaptopurine, and abasic guanosine analog (e.g., ganciclovir) activation, studies have only recently focused on the molecular basis of the structure to function relationship of a mammalian guanylate kinase. As a means to evaluate the details of amino acid side chain involvement in substrate interaction, we have constructed a conditional guanylate-kinase-deficient Escherichia coli strain that requires the presence of a functional, plasmid-borne guanylate kinase for growth under selective conditions. Positive genetic selection provides a rapid mechanism to identify not only functional guanylate kinase mutants but also those that result in drug resistance. This novel strain will be beneficial to assess the role of specific amino acids of guanylate kinase in structure, function, drug activation, and drug resistance.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.